Viewing Study NCT00772668


Ignite Creation Date: 2025-12-24 @ 5:49 PM
Ignite Modification Date: 2026-01-02 @ 11:47 AM
Study NCT ID: NCT00772668
Status: TERMINATED
Last Update Posted: 2017-12-11
First Post: 2008-10-12
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Rituximab, Cyclophosphamide, Bortezomib, and Prednisone in Patients With Stage III/IV FL or MZL
Sponsor: University of Miami
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2009-09-25
Start Date Type: ACTUAL
Primary Completion Date: 2010-12
Primary Completion Date Type: ACTUAL
Completion Date: 2011-02
Completion Date Type: ACTUAL
First Submit Date: 2008-10-12
First Submit QC Date: None
Study First Post Date: 2008-10-15
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2013-01-18
Results First Submit QC Date: None
Results First Post Date: 2013-02-21
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-11-06
Last Update Post Date: 2017-12-11
Last Update Post Date Type: ACTUAL